{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T17:35:08Z","timestamp":1725816908767},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1995,11,1]],"date-time":"1995-11-01T00:00:00Z","timestamp":815184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1995,11]]},"DOI":"10.1007\/bf00685797","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T08:31:06Z","timestamp":1101717066000},"page":"477-482","source":"Crossref","is-referenced-by-count":4,"title":["Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron"],"prefix":"10.1007","volume":"36","author":[{"given":"Carolien P.","family":"Schr\u00f6der","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winette T. A.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido P.","family":"Kema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Groenewegen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk Th.","family":"Sleijfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth G. E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/bjc.1990.395","volume":"62","author":"NM Barnes","year":"1990","unstructured":"Barnes NM, Ge J, Jones WG, Naylor RJ, Rudd JA (1990) Cisplatin induced emesis: preliminary results indicative of changes in plasma levels of 5-hydroxytryptamine. Br J Cancer 62: 862","journal-title":"Br J Cancer"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(60)90773-X","volume":"I","author":"G Bertaccini","year":"1960","unstructured":"Bertaccini G, Chieppa S (1960) Urinary excretion of 5-hydroxyindoleacetic acid after removal of the large intestine in man. Lancet I: 881","journal-title":"Lancet"},{"issue":"Suppl","key":"CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0959-8049(92)90631-B","volume":"28A","author":"GH Blijham","year":"1992","unstructured":"Blijham GH (1992) Does granisetron remain effective over multiple cycles? Eur J Cancer 28A [Suppl]: 17","journal-title":"Eur J Cancer"},{"issue":"Suppl 3","key":"CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00003495-199200433-00006","volume":"43","author":"U Bruntsch","year":"1992","unstructured":"Bruntsch U, Drechsler S, Hiller E, Eiermann W, Tulusan AH, Buhner M, Hartenstein R, Koenig HJ, Gallmeier WM (1992) Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy: comparing tropisetron with optimised standard antiemetic therapy. Drugs 43 [Suppl 3]: 23","journal-title":"Drugs"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM199003223221204","volume":"322","author":"LX Cubeddu","year":"1990","unstructured":"Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL (1990) Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322: 810","journal-title":"N Engl J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/bjc.1992.242","volume":"66","author":"LX Cubeddu","year":"1992","unstructured":"Cubeddu LX, Hoffmann IS, Fuenmayor NT, Malave JJ (1992) Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs. Br J Cancer 66: 198","journal-title":"Br J Cancer"},{"issue":"Suppl 188","key":"CR7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/00365529109111236","volume":"26","author":"MJG Farthing","year":"1991","unstructured":"Farthing MJG (1991) 5-Hydroxytryptamine and 5-hydroxytryptamine-3 receptor antagonists. Scand J Gastroenterol 26 [Suppl 188]: 92","journal-title":"Scand J Gastroenterol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.1990.tb16873.x","volume":"600","author":"RW Fuller","year":"1990","unstructured":"Fuller RW, Wong DT (1990) Serotonin uptake and serotonin uptake inhibition. Ann NY Acad Sci 600: 68","journal-title":"Ann NY Acad Sci"},{"issue":"Suppl","key":"CR9","first-page":"9","volume":"27","author":"DR Gandara","year":"1991","unstructured":"Gandara DR (1991) Progress in the control of acute and delayed emesis induced by cisplatin. Eur J Cancer 27 [Suppl]: 9","journal-title":"Eur J Cancer"},{"key":"CR10","first-page":"27","volume-title":"Serotonin and the cardiovascular system","author":"CN Gillis","year":"1985","unstructured":"Gillis CN (1985) Peripheral metabolism of serotonin. In: Van-Houtte PM (ed) Serotonin and the cardiovascular system. Raven Press, New York, p 27"},{"issue":"Suppl 1","key":"CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003495-198300251-00007","volume":"25","author":"RJ Gralla","year":"1983","unstructured":"Gralla RJ (1983) Metoclopramide: a review of antiemetic trials. Drugs 25 [Suppl 1]: 63","journal-title":"Drugs"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM198110153051601","volume":"305","author":"RJ Gralla","year":"1981","unstructured":"Gralla RJ, Itri LM, Pisko SE, Squillante AE, Kelsen DP, Braun DW Jr, Bordin LA, Braun TJ, Young CW (1981) Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy induced nausea and vomiting. N Engl J Med 305: 905","journal-title":"N Engl J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/clinchem\/38.4.534","volume":"38","author":"IP Kema","year":"1992","unstructured":"Kema IP, De Vries EGE, Schellings AMJ, Postmus PE, Muskiet FAJ (1992) Improved diagnosis of carcinoid tumors by measurement of platelet serotonin. Clin Chem 38: 534","journal-title":"Clin Chem"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/000456328402100515","volume":"21","author":"E Kwarts","year":"1984","unstructured":"Kwarts E, Kwarts J, Rutgers H (1984) A simple paired-ion liquid chromatography assay for serotonin in cerebrospinal fluid, platelet rich plasma, serum and urine. Ann Clin Biochem 21: 425","journal-title":"Ann Clin Biochem"},{"issue":"Suppl 1","key":"CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198300251-00002","volume":"25","author":"J Laszlo","year":"1983","unstructured":"Laszlo J (1983) Nausea and vomiting as major complications of cancer chemotherapy. Drugs 25 [Suppl 1]: 1","journal-title":"Drugs"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199003223221205","volume":"322","author":"M Marty","year":"1990","unstructured":"Marty M, Pouillart P, Scholl S, Droz JP, Azab M, Brion N, Pujade-Lauraine E, Paule B, Paes D, Bons J (1990) Comparison of the 5-hydroxytryptamine-3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin induced emesis. N Engl J Med 322: 816","journal-title":"N Engl J Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01819832","volume":"1","author":"S Milano","year":"1991","unstructured":"Milano S, Simon C, Grelot L (1991) In vitro release and tissue levels of ileal serotonin after cisplatin-induced emesis in the cat. Clin Auton Res 1: 275","journal-title":"Clin Auton Res"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bjc.1987.177","volume":"56","author":"WD Miner","year":"1987","unstructured":"Miner WD, Sanger GJ, Turner DH (1987) Evidence that 5-HT3 receptors mediate cytotoxic drug and radiation-evoked emesis. Br J Cancer 56: 159","journal-title":"Br J Cancer"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-113-11-834","volume":"113","author":"PHM Mulder de","year":"1990","unstructured":"Mulder PHM de, Seynaeve C, Vermorken JB, Van Liessum PA, Mols-Jevdevic S, Allman EL, Beranek P, Verweij J (1990) Ondansetron compared with high-dose metoclopramide in the prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. Ann Intern Med 113: 834","journal-title":"Ann Intern Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0167-5273(87)90007-6","volume":"14","author":"A Pletscher","year":"1987","unstructured":"Pletscher A (1987) The hydroxytryptamine system of blood platelets: physiology and pathophysiology. Int J Cardiol 14: 177","journal-title":"Int J Cardiol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/clinchem\/28.1.207","volume":"28","author":"TG Rosano","year":"1992","unstructured":"Rosano TG, Meola JM, Swift TA (1992) Liquid-chromatographic determination of urinary 5-hydroxy-3-indoleacetic acid, with fluorescence detection. Clin Chem 28: 207","journal-title":"Clin Chem"},{"key":"CR22","first-page":"37","volume-title":"Serotonin and the cardiovascular system","author":"JF Stolz","year":"1985","unstructured":"Stolz JF (1985) Uptake and storage of serotonin by platelets. In: VanHoutte PM (ed) Serotonin and the cardiovascular system. Raven Press, New York, p 37"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2036.1992.tb00050.x","volume":"6","author":"NJ Talley","year":"1992","unstructured":"Talley NJ (1992) 5-Hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications (review). Aliment Pharmacol Ther 6: 273","journal-title":"Aliment Pharmacol Ther"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/1097-0142(19931001)72:7<2239::AID-CNCR2820720729>3.0.CO;2-5","volume":"72","author":"OHG Wilder-Smith","year":"1993","unstructured":"Wilder-Smith OHG, Borgeat A, Chappuis P, Fathi M, Forni M (1993) Urinary serotonin metabolite excretion during cisplatin chemotherapy. Cancer 72: 2239","journal-title":"Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685797.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00685797\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T11:13:15Z","timestamp":1585998795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00685797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["BF00685797"],"URL":"https:\/\/doi.org\/10.1007\/bf00685797","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,11]]}}}